QS Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | $249K | Hold |
2,974
| – | – | ﹤0.01% | 1000 |
|
2021
Q1 | $225K | Sell |
2,974
-1,200
| -29% | -$90.8K | ﹤0.01% | 1076 |
|
2020
Q4 | $366K | Buy |
4,174
+479
| +13% | +$42K | ﹤0.01% | 919 |
|
2020
Q3 | $282K | Hold |
3,695
| – | – | ﹤0.01% | 944 |
|
2020
Q2 | $456K | Sell |
3,695
-600
| -14% | -$74K | 0.01% | 929 |
|
2020
Q1 | $363K | Sell |
4,295
-1,200
| -22% | -$101K | 0.01% | 919 |
|
2019
Q4 | $462K | Hold |
5,495
| – | – | ﹤0.01% | 961 |
|
2019
Q3 | $371K | Hold |
5,495
| – | – | ﹤0.01% | 1031 |
|
2019
Q2 | $471K | Hold |
5,495
| – | – | 0.01% | 989 |
|
2019
Q1 | $489K | Sell |
5,495
-12
| -0.2% | -$1.07K | 0.01% | 986 |
|
2018
Q4 | $469K | Hold |
5,507
| – | – | 0.01% | 925 |
|
2018
Q3 | $534K | Sell |
5,507
-1,769
| -24% | -$172K | 0.01% | 944 |
|
2018
Q2 | $685K | Buy |
7,276
+10
| +0.1% | +$941 | 0.01% | 873 |
|
2018
Q1 | $589K | Hold |
7,266
| – | – | 0.01% | 901 |
|
2017
Q4 | $648K | Buy |
7,266
+185
| +3% | +$16.5K | 0.01% | 880 |
|
2017
Q3 | $659K | Sell |
7,081
-7
| -0.1% | -$651 | 0.01% | 885 |
|
2017
Q2 | $644K | Sell |
7,088
-900
| -11% | -$81.8K | 0.01% | 864 |
|
2017
Q1 | $701K | Buy |
7,988
+6,200
| +347% | +$544K | 0.01% | 875 |
|
2016
Q4 | $148K | Hold |
1,788
| – | – | ﹤0.01% | 1183 |
|
2016
Q3 | $165K | Buy |
1,788
+5
| +0.3% | +$461 | ﹤0.01% | 1130 |
|
2016
Q2 | $139K | Sell |
1,783
-8
| -0.4% | -$624 | ﹤0.01% | 1179 |
|
2016
Q1 | $148K | Sell |
1,791
-304
| -15% | -$25.1K | ﹤0.01% | 1138 |
|
2015
Q4 | $219K | Buy |
2,095
+16
| +0.8% | +$1.67K | ﹤0.01% | 1071 |
|
2015
Q3 | $219K | Hold |
2,079
| – | – | ﹤0.01% | 1050 |
|
2015
Q2 | $284K | Hold |
2,079
| – | – | ﹤0.01% | 997 |
|
2015
Q1 | $259K | Hold |
2,079
| – | – | ﹤0.01% | 1003 |
|
2014
Q4 | $188K | Buy |
+2,079
| New | +$188K | ﹤0.01% | 1025 |
|